Price T Rowe Associates Inc Dyne Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

  • $935 Billion
  • Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,398,087 shares of DYN stock, worth $26.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,398,087
Previous 2,383,953 41.35%
Holding current value
$26.3 Million
Previous $22.7 Million 22.07%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$8.18 - $14.22 $8.06 Million - $14 Million
-985,866 Reduced 41.35%
1,398,087 $17.7 Million
Q2 2025

Aug 14, 2025
BUY
$6.81 - $14.78 $3.84 Million - $8.33 Million
563,538 Added 30.96%
2,383,953 $22.7 Million
Q1 2025

May 14, 2025
SELL
$10.46 - $25.46 $6.09 Million - $14.8 Million
-582,037 Reduced 24.23%
1,820,415 $19 Million
Q4 2024

Feb 14, 2025
SELL
$23.56 - $35.55 $5.51 Million - $8.31 Million
-233,841 Reduced 8.87%
2,402,452 $56.6 Million
Q3 2024

Nov 14, 2024
BUY
$31.94 - $47.04 $8.63 Million - $12.7 Million
270,224 Added 11.42%
2,636,293 $94.7 Million
Q2 2024

Aug 14, 2024
BUY
$23.65 - $35.63 $29.2 Million - $44 Million
1,233,977 Added 109.0%
2,366,069 $83.5 Million
Q1 2024

May 15, 2024
BUY
$13.06 - $29.18 $14.6 Million - $32.6 Million
1,118,590 Added 8284.62%
1,132,092 $32.1 Million
Q4 2023

Feb 14, 2024
SELL
$6.62 - $13.64 $1.07 Million - $2.21 Million
-161,885 Reduced 92.3%
13,502 $180,000
Q3 2023

Nov 14, 2023
BUY
$8.6 - $12.18 $1.41 Million - $2 Million
164,444 Added 1502.73%
175,387 $1.57 Million
Q2 2023

Aug 14, 2023
SELL
$8.53 - $14.28 $2.39 Million - $4 Million
-280,367 Reduced 96.24%
10,943 $124,000
Q1 2023

May 15, 2023
BUY
$10.88 - $15.0 $2.74 Million - $3.78 Million
252,232 Added 645.46%
291,310 $3.36 Million
Q4 2022

Feb 14, 2023
BUY
$9.37 - $13.8 $3,466 - $5,106
370 Added 0.96%
39,078 $453,000
Q3 2022

Nov 14, 2022
BUY
$7.2 - $15.17 $15,465 - $32,585
2,148 Added 5.88%
38,708 $493,000
Q2 2022

Aug 15, 2022
BUY
$4.36 - $10.5 $444 - $1,071
102 Added 0.28%
36,560 $251,000
Q1 2022

May 16, 2022
BUY
$6.52 - $12.27 $4,564 - $8,589
700 Added 1.96%
36,458 $351,000
Q4 2021

Feb 14, 2022
SELL
$11.89 - $16.07 $7,134 - $9,642
-600 Reduced 1.65%
35,758 $425,000
Q3 2021

Nov 15, 2021
BUY
$15.6 - $21.46 $567,184 - $780,242
36,358 New
36,358 $590,000
Q1 2021

May 17, 2021
SELL
$14.0 - $29.3 $6.79 Million - $14.2 Million
-484,952 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$16.81 - $23.94 $8.15 Million - $11.6 Million
484,952 New
484,952 $10.2 Million

Others Institutions Holding DYN

# of Institutions
227
Shares Held
148M
Call Options Held
184K
Put Options Held
243K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $975M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email